Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution and bioactivity in mice
Pancreatic cancer (PC) is one of the most lethal malignancies, primarily due to its dense extra-cellular matrix and poor vascularization, which limit effective drug accumulation and therapy. Here, we describe a local siRNA delivery system using thermosensitive hydrogel-embedded na-noparticles (NPs)....
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Andover House Inc.
2025-04-01
|
| Series: | Precision Nanomedicine |
| Online Access: | https://doi.org/10.33218/001c.136412 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849700529571102720 |
|---|---|
| author | Majd Agbaria Doaa Jbara-Agbaria Gershon Golomb |
| author_facet | Majd Agbaria Doaa Jbara-Agbaria Gershon Golomb |
| author_sort | Majd Agbaria |
| collection | DOAJ |
| description | Pancreatic cancer (PC) is one of the most lethal malignancies, primarily due to its dense extra-cellular matrix and poor vascularization, which limit effective drug accumulation and therapy. Here, we describe a local siRNA delivery system using thermosensitive hydrogel-embedded na-noparticles (NPs). siRNA against VAV1 (siVAV1), a key protein implicated in PC, was encapsu-lated in poly(lactic-co-glycolic acid) (PLGA)-based NPs decorated with an ApoB-derived peptide as the targeting ligand. The ApoB-targeted NPs exhibited optimal physicochemical properties, including nanoscale size, low polydispersity index, and a neutral charge. The sustained-release siRNA-NPs were incorporated into a thermosensitive hydrogel (poloxamer) and locally injected into the pancreas of tumor-bearing mice. Treatment with targeted NPs in gel (tNPs@G) resulted in a notable increase in accumulation within the tumor (1.9-fold) and spleen (1.3-fold) 72 hours post-injection, with minimal systemic exposure and no local cytotoxicity. Intra-tumoral implan-tation of the gel-laden siVAV1 NPs in PC-bearing mice led to a significant reduction in tumor growth and volume (2.6-fold), mediated by the inhibition of both VAV1 mRNA and protein, and improved survival rates. The developed local siRNA delivery system provides a minimally in-vasive and effective therapeutic approach for PC, addressing key drug delivery barriers. |
| format | Article |
| id | doaj-art-a432018bd3f744e8ac83c44264da149c |
| institution | DOAJ |
| issn | 2639-9431 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Andover House Inc. |
| record_format | Article |
| series | Precision Nanomedicine |
| spelling | doaj-art-a432018bd3f744e8ac83c44264da149c2025-08-20T03:18:13ZengAndover House Inc.Precision Nanomedicine2639-94312025-04-018210.33218/001c.136412Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution and bioactivity in miceMajd AgbariaDoaa Jbara-AgbariaGershon GolombPancreatic cancer (PC) is one of the most lethal malignancies, primarily due to its dense extra-cellular matrix and poor vascularization, which limit effective drug accumulation and therapy. Here, we describe a local siRNA delivery system using thermosensitive hydrogel-embedded na-noparticles (NPs). siRNA against VAV1 (siVAV1), a key protein implicated in PC, was encapsu-lated in poly(lactic-co-glycolic acid) (PLGA)-based NPs decorated with an ApoB-derived peptide as the targeting ligand. The ApoB-targeted NPs exhibited optimal physicochemical properties, including nanoscale size, low polydispersity index, and a neutral charge. The sustained-release siRNA-NPs were incorporated into a thermosensitive hydrogel (poloxamer) and locally injected into the pancreas of tumor-bearing mice. Treatment with targeted NPs in gel (tNPs@G) resulted in a notable increase in accumulation within the tumor (1.9-fold) and spleen (1.3-fold) 72 hours post-injection, with minimal systemic exposure and no local cytotoxicity. Intra-tumoral implan-tation of the gel-laden siVAV1 NPs in PC-bearing mice led to a significant reduction in tumor growth and volume (2.6-fold), mediated by the inhibition of both VAV1 mRNA and protein, and improved survival rates. The developed local siRNA delivery system provides a minimally in-vasive and effective therapeutic approach for PC, addressing key drug delivery barriers.https://doi.org/10.33218/001c.136412 |
| spellingShingle | Majd Agbaria Doaa Jbara-Agbaria Gershon Golomb Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution and bioactivity in mice Precision Nanomedicine |
| title | Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution and bioactivity in mice |
| title_full | Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution and bioactivity in mice |
| title_fullStr | Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution and bioactivity in mice |
| title_full_unstemmed | Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution and bioactivity in mice |
| title_short | Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution and bioactivity in mice |
| title_sort | localized delivery of gel embedded sirna nanoparticles for pancreatic cancer treatment formulation biodistribution and bioactivity in mice |
| url | https://doi.org/10.33218/001c.136412 |
| work_keys_str_mv | AT majdagbaria localizeddeliveryofgelembeddedsirnananoparticlesforpancreaticcancertreatmentformulationbiodistributionandbioactivityinmice AT doaajbaraagbaria localizeddeliveryofgelembeddedsirnananoparticlesforpancreaticcancertreatmentformulationbiodistributionandbioactivityinmice AT gershongolomb localizeddeliveryofgelembeddedsirnananoparticlesforpancreaticcancertreatmentformulationbiodistributionandbioactivityinmice |